This article was written by LPR Reader Krista Madere from . If you would like a letter to the editor posted, click the Submission Tab above ormessage us on Facebook !
As an occupational therapist, I have witnessed the power of biopharmaceutical innovation many times over. In my career, I have been fortunate to help hundreds of patients gain better control over their tremors. But oftentimes, it can be hard to find the perfect solution. My own grandfather was diagnosed with Parkinson’s, a debilitating and progressive disease. He used to love dining out, but as his hand tremors worsened, he became too embarrassed to even visit a restaurant. Unfortunately, there is no cure yet for Parkinson’s disease, but I have hope. Just look at the past year. We have all seen how powerful innovation can be. Because of our biopharmaceutical companies and their commitment to fighting against COVID-19, we are finally able to close the door on this pandemic. It’s critical that legislators protect scientific progress, and that means rejecting price-setting proposals that could halt future COVID-19 treatment research or even new efforts to find a cure for Parkinson’s. We need to make sure we support the industry trying to keep us healthy and safe. I hope our leaders in Washington, DC make the right decision and oppose these restrictive policies that ultimately harm patients like my late grandfather. Sincerely, Krista Madere